I. Chen

发表

Molecular Mechanisms of TLR2-Mediated Antigen Cross-Presentation in Dendritic Cells

P. Chong, K. Shen, Ying C. Song, 2014, The Journal of Immunology.

Cells Antigen Cross-Presentation in Dendritic Molecular Mechanisms of TLR2-Mediated

P. Chong, K. Shen, Ying C. Song, 2014 .

The ORF8 Protein of SARS-CoV-2 Modulates the Spike Protein and Its Implications in Viral Transmission

J. Tsai, I. Chen, M. Tsai, 2022, Frontiers in Microbiology.

TGF-β and IL-21 cooperatively stimulate activated CD8(+) T cells to differentiate into Tc17 cells.

I. Chen, Hsin-Wei Chen, C. Hsieh, 2016, Immunology letters.

A triterpenoid methyl antcinate K isolated from Antrodia cinnamomea promotes dendritic cell activation and Th2 differentiation

K. Shen, I. Chen, C. Chu, 2009, European journal of immunology.

A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor Immunity

Y. Sher, K. Shen, I. Chen, 2020, Vaccines.

A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model

Y. Sher, I. Chiang, S. Roffler, 2015, Oncotarget.

Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses.

P. Chong, I. Chen, C. Leng, 2009, Vaccine.

A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy

P. Chong, Ying C. Song, I. Chen, 2014, BioMed research international.

Toll-Like Receptor 9-Mediated Protection of Enterovirus 71 Infection in Mice Is Due to the Release of Danger-Associated Molecular Patterns

P. Chong, I. Chen, Shih-Jen Liu, 2014, Journal of Virology.

Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery.

I. Chen, Shih-Jen Liu, Chung-Hsiung Huang, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model

J. Chen, P. Chong, K. Shen, 2012, PloS one.

Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide

P. Chong, K. Shen, Ying C. Song, 2014, Human vaccines & immunotherapeutics.

Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy

Y. Sher, K. Shen, I. Chen, 2019, Vaccine: X.

Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.

Y. Sher, S. Roffler, I. Chen, 2016, Cancer letters.

Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine.

Y. Sher, I. Chen, Shih-Jen Liu, 2019, American journal of cancer research.

Generation and characterization of JSRV envelope transgenic mice in FVB background.

I. Chen, Y. Chow, Jen-hao Chen, 2009, Virology.

A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity.

Y. Sher, I. Chen, C. Leng, 2018, American journal of cancer research.

Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice.

P. Chong, I. Chen, C. Leng, 2016, Vaccine.

Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns

P. Chong, I. Chen, Shih-Jen Liu, 2014 .